Hepatitis C

Erscheinungsjahr 2012
ISBN: 978-0-19-984429-6
Verlag: Oxford University Press

Buch, Englisch, 224 Seiten, Format (B × H): 127 mm x 203 mm, Gewicht: 248 g

Reihe: Oxford American Infectious Disease Library

Rapid and profound changes are taking place in the field of hepatitis C therapeutics. More than ever, these changes necessitate a current, clinically pertinent review of the broader scope of hepatitis C, including its epidemiology, diagnosis, natural history, and clinical features. This handbook provides that concise survey of the field. Acute and chronic hepatitis C are addressed as are important new treatment options for hepatitis C, management of side effects,
and a convenient summary of clinical trials on the treatment of chronic hepatitis C. Part of the Oxford American Infectious Disease Library, this evidence-based clinical resource will appeal to clinicians directly involved in the care of patients with hepatitis C.

Zielgruppe

Infectious disease clinicians; gastroenterology/hepatology clinicians; primary care clinicians

Autoren/Hrsg.

Jensen, Donald

Reau, Nancy

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Allgemeinmedizin, Familienmedizin
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Infektionskrankheiten
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Hepatologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Gastroentereologie, Proktologie

Inhaltsverzeichnis

1. Basic Virology
2. Epidemiology of Hepatitis
3. Natural History of Hepatitis
4. Diagnostic Testing
5. Pathology of Viral Hepatitis
6. Acute Hepatitis
7. Chronic Hepatitis
8. Extrahepatic Manifestations of Hepatitis
9. Hepatitis C in Liver Transplantation
10. Treatment of Hepatitis
11. Side Effect Management of Peginterferon and Ribavirin
12. Hepatitis C in Special Populations
13. New Treatments: Telaprevir and Boceprevir
14. HCV Directly Acting Antiviral Therapies
(Other than Boceprevir and Telaprevir)
15. Lexicon of Trials for Treatment of Chronic Hepatitis C
Appendix 197

Über Autor(innen)

Donald Jensen is the Director of the Center for Liver Disease, and is a Professor of Medicine at the University of Chicago Medical Center, Chicago, IL

Nancy Reau is an Associate Professor of Medicine at the Center for Liver Disease, University of Chicago Medical Center, Chicago, IL